Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines
NCT02580370 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 450
Last updated 2016-09-09
Summary
This is a safety and efficacy study of botulinum toxin type A in subjects with lateral canthal lines.
Conditions
- Skin Aging
Interventions
- BIOLOGICAL
-
Botulinum toxin type A
Topical botulinum toxin type A
- BIOLOGICAL
-
Placebo comparator
Topical placebo comparator
Sponsors & Collaborators
-
Revance Therapeutics, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2016-07-31
- Completion
- 2016-08-31
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
NCT00884234 ·Status: COMPLETED ·Phase: PHASE2
-
A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
NCT01124552 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
NCT01940991 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation
NCT06385171 ·Status: RECRUITING
-
ET-01 in Subjects With Lateral Canthal Lines, LCL-207
NCT03655691 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
NCT01776606 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines
NCT02236312 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Moderate to Severe Lateral Canthal Lines
NCT04249687 ·Status: COMPLETED ·Phase: PHASE3
-
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I
NCT02677298 ·Status: COMPLETED ·Phase: PHASE3
-
MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines
NCT03732833 ·Status: COMPLETED ·Phase: PHASE3
-
MT10109L in the Treatment of Lateral Canthal Lines
NCT03785145 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
NCT01124565 ·Status: COMPLETED ·Phase: PHASE2
-
BOTOX® in the Treatment of Crow's Feet Lines in China
NCT02195687 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines
NCT04143854 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines
NCT04622254 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines
NCT03736928 ·Status: COMPLETED ·Phase: PHASE2
-
Brow Enhancement Study
NCT01308593 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)
NCT06585696 ·Status: COMPLETED ·Phase: PHASE3
-
A Confirmatory Study for Evaluation of the Treatment by the Celluma3 of Periorbital Wrinkles
NCT02543970 ·Status: COMPLETED
-
A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows
NCT00752258 ·Status: COMPLETED ·Phase: PHASE3
-
BTL-785F Device for Non-invasive Facial Rejuvenation in Patients Injected With Botulinum Toxin
NCT05524766 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines
NCT04594213 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
NCT01818076 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows
NCT00752297 ·Status: COMPLETED ·Phase: PHASE3
-
Lateral Canthal Rhytides With Medium Depth Chemical Peel With or Without Pretreatment With Botulinum Toxin A
NCT01586819 ·Status: COMPLETED ·Phase: PHASE3